Your provider will review your medical history, current medications, recent labs (if available), and goals, then recommend whether and how to proceed
Neuropsychopharmacology 46 , 288296 (2021)
Thirteen states cover GLP-1s for obesity treatment under Medicaid, according to a January 2026 report from KFF, a nonpartisan research organization focused on health policy
What are the expected benefits and potential risks
Below, we help you pick the right template to get started, whether you need a blank 12 week weight loss tracker or a simple daily log
Its about understanding the why behind your choices so that you can create real, sustainable change